iMGP DBi Hedge Strategy ETF
NYSEARCA:DBEHThe iMGP DBi Hedge Strategy ETF (DBEH) is an exchange-traded fund that mostly invests in multi-strategy alternatives. The fund is an actively managed fund that seeks to model the performance of long\u002Fshort equity hedge fund strategies via US futures contracts. The fund seeks long-term capital appreciation. DBEH was launched on Dec 18, 2019 and is managed by iM.
First Trust Asia Pacific ex-Japan AlphaDEX Fund
NASDAQ:FPAThe First Trust Asia Pacific Ex-Japan AlphaDEX Fund (FPA) is an exchange-traded fund that mostly invests in total market equity. The fund selects and weights 100 stocks from the S&P Asia Pacific Ex-Japan BMI Index based on their growth and value factors. FPA was launched on Apr 18, 2011 and is managed by First Trust.
Belgravia Capital International Inc,
TSE:ICPBelgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.
Pernix Therapeutics
NASDAQ:PTXPernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.
UTime
NASDAQ:UTMEUTime Limited, together with its subsidiaries, designs, develops, manufactures, sells, and operates mobile phones, accessories, and related consumer electronics. The company offers consumer electronics, such as power banks, bluetooth speakers, batteries, chargers, cell phone parts, molds, and shells. It provides electronics manufacturing services, including original equipment manufacturer and original design manufacturer services. It sells its products under the UTime and Do brand names in South America, South Asia, Southeast Asia, and Africa. UTime Limited was founded in 2008 and is headquartered in Shenzhen, China.